Wild Biotech

Company Overview

Snapshot

Founded in April 2019 by Neta Raab, Ido Bachelet, and Gal Zanir, Wild Biotech operates with 1–10 employees. The company has secured funding across one round from Marius Nacht and Tech.bio, to advance its AI-powered drug discovery platform. In March 2021, the company gained significant media attention for its innovative approach to drug development.

Business overview

Wild Biotech is developing an AI-powered drug discovery platform focused on creating new medicines for a wide range of illnesses. The company leverages an annotated metagenomic database of wild animal microbiota, utilizing artificial intelligence to organize and analyze gut microbes based on associations with animal diets, activity, and lifespans. Wild Biotech manages an end-to-end process from field exploration to drug development and clinical trials, currently focusing on inflammatory, immune, and gastrointestinal diseases with several lead compounds in preclinical stages. The company operates within the Health Tech & Life Sciences sector, specifically in Pharmaceuticals and Biotechnology, with a core technology in Artificial Intelligence and Biologicals.

Strategic signal

In March 2021, Wild Biotech garnered significant media attention from publications like Fierce Biotech and BioWorld for its unique approach to drug discovery, which involves surveying gut microbes from wild animals to identify new treatments for human diseases. This coverage highlights the company's innovative methodology and validates its potential to disrupt traditional drug development paradigms, signaling strong early-stage interest from the scientific and investment communities.

Company Intelligence Q&A

What is Wild Biotech's core technology?

Wild Biotech utilizes an AI-powered drug discovery platform that employs de novo metagenome assembly to analyze and organize gut microbes from wild animal microbiota. This technology helps identify potential new medicines by correlating microbial data with factors like animal diets, activity, and lifespans.

When was Wild Biotech founded and by whom?

Wild Biotech was founded in April 2019 by Neta Raab, Ido Bachelet, and Gal Zanir.

Which therapeutic areas is Wild Biotech currently focusing on?

Wild Biotech is currently in the preclinical stage with several lead compounds targeting inflammatory, immune, and gastrointestinal diseases.

What was a notable recent development for Wild Biotech?

In March 2021, Wild Biotech was featured in several industry publications, including Fierce Biotech and BioWorld, for its innovative approach to discovering new drugs by studying gut microbes from wild animals.